If, as looks likely, more medicines will come in the form of injectables in the next five to ten years, then more life-saving medicines will be…
In Conversation
Despite global economic challenges, [India's pharmaceutical sector] has demonstrated robustness... We are determined to leverage this momentum
I am optimistic that diabetes care will improve. The inequality of care in Europe and Portugal exists, and it is really important to plan how we…
A collaborative environment … can potentially position Portugal on par with Spain in the clinical research landscape within the next five years
One of the pivotal aspects that we emphasise when engaging with international stakeholders is Portugal's robust scientific network and the quality of its scientific research
Science is doing its part in bringing amazing developments forward. We need to work on creating a world where politics follow science and pursue people’s well-being
Quicker access to innovation proves to be not only beneficial for patients but also cost-effective for the healthcare system
I firmly believe that true diversity leads to quality outcomes, benefiting projects and initiatives across the organization
Our top priority remains fostering an innovation-friendly environment, ensuring that new prevention and treatment breakthroughs reach the people and patients that will most benefit from them…
India, to me, has always been an intriguing puzzle, and if you can decipher it, it becomes a goldmine of opportunities
The nation's resilience in the face of global supply disruptions reflects its growing importance in the global landscape
I see STADA becoming one of the top three companies in Consumer Health Care and top six in Generics [in Portugal] without a shadow of a…
